Proposed CD4+ T-cell criteria for staging human immunodeficiency virus-infected Chinese adults

被引:11
作者
Kam, KM
Wong, KH
Li, PCK
Lee, SS
Leung, WL
Kwok, MY
机构
[1] Hong Kong Special Adm Reg Govt, Dept Hlth, Publ Hlth Lab, Pathol Serv, Sai Ying Pun, Peoples R China
[2] Queen Elizabeth Hosp, Special Med Serv, Kowloon, Peoples R China
[3] Yaumati Polyclin, Dept Hlth, AIDS Unit, Kowloon, Peoples R China
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1998年 / 89卷 / 01期
关键词
D O I
10.1006/clin.1998.4570
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The present treatment, prophylaxis, and prognostic staging of human immunodeficiency virus (HIV) disease rely heavily on peripheral CD4(+) T lymphocyte (CD4) changes. We correlated the clinical course of events and CD4 changes among consecutive HIV-infected ethnic Chinese adults in Hong Kong. Using death as end point, the estimated proportion survival and death incidences were used to compare CDC and proposed staging criteria based on stratified baseline CD4. A separate set of baseline CD4 per microliter (/mu l) (percentage lymphocytes) stratification criteria of 1, >220/mu l (>12%); 2, 100-220/mu l (6-12%); and 3, <100/mu l, (<6%) is proposed which can be used for staging HIV-infected Chinese adults. For our study population, our proposed criteria for stratifying baseline CD4 gave better discrimination and more predictive power than the CDC criteria, We assessed the potential impact of these new proposed criteria on anti-retroviral treatment and prophylaxis against opportunistic infections in our adult HIV-infected population. (C) 1998 Academic Press.
引用
收藏
页码:11 / 22
页数:12
相关论文
共 61 条
[1]   CORRELATES OF THE RATE OF DECLINE OF CD4+ LYMPHOCYTES AMONG INJECTION-DRUG USERS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS [J].
ALCABES, P ;
SCHOENBAUM, EE ;
KLEIN, RS .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (09) :989-1000
[2]  
Altman DG., 1991, PRACTICAL STAT MED R
[3]   CD4(+) T-lymphocyte counts in HIV infection: Are European standards applicable to African patients? [J].
Anglaret, X ;
Diagbouga, S ;
Mortier, E ;
Meda, N ;
VergeValette, V ;
SyllaKoko, F ;
Cousens, S ;
Laruche, G ;
Ledru, E ;
Bonard, D ;
Dabis, F ;
VandePerre, P .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 14 (04) :361-367
[4]  
[Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
[5]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[6]   BIASES IN PREVALENT COHORTS [J].
BROOKMEYER, R ;
GAIL, MH .
BIOMETRICS, 1987, 43 (04) :739-749
[7]   Antiretroviral therapy for HIV infection in 1996 - Recommendations of an international panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02) :146-154
[8]   PNEUMOCYSTIS PROPHYLAXIS AND SURVIVAL IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION TREATED WITH ZIDOVUDINE [J].
CHAISSON, RE ;
KERULY, J ;
RICHMAN, DD ;
MOORE, RD .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (10) :2009-2013
[9]   INVITRO INFECTION OF NATURAL-KILLER-CELLS WITH DIFFERENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES [J].
CHEHIMI, J ;
BANDYOPADHYAY, S ;
PRAKASH, K ;
PERUSSIA, B ;
HASSAN, NF ;
KAWASHIMA, H ;
CAMPBELL, D ;
KORNBLUTH, J ;
STARR, SE .
JOURNAL OF VIROLOGY, 1991, 65 (04) :1812-1822
[10]   A PILOT-STUDY OF LOW-DOSE ZIDOVUDINE IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
COLLIER, AC ;
BOZZETTE, S ;
COOMBS, RW ;
CAUSEY, DM ;
SCHOENFELD, DA ;
SPECTOR, SA ;
PETTINELLI, CB ;
DAVIES, G ;
RICHMAN, DD ;
LEEDOM, JM ;
KIDD, P ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1015-1021